These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 14966347)

  • 1. Detection of aberrant p16INK4A methylation in sera of patients with liver cirrhosis and hepatocellular carcinoma.
    Chu HJ; Heo J; Seo SB; Kim GH; Kang DH; Song GA; Cho M; Yang US
    J Korean Med Sci; 2004 Feb; 19(1):83-6. PubMed ID: 14966347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chronic hepatitis B virus infection and the methylation status of p16INK4A promoter].
    Zhu R; Li BZ; Ling YQ; Zhang HP; Li H; Liu Y; Hu XQ; Zhu HG
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):166-70. PubMed ID: 17649629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation status of p14ARF, p15INK4b, and p16INK4a genes in human hepatocellular carcinoma.
    Fukai K; Yokosuka O; Imazeki F; Tada M; Mikata R; Miyazaki M; Ochiai T; Saisho H
    Liver Int; 2005 Dec; 25(6):1209-16. PubMed ID: 16343074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma.
    Roncalli M; Bianchi P; Bruni B; Laghi L; Destro A; Di Gioia S; Gennari L; Tommasini M; Malesci A; Coggi G
    Hepatology; 2002 Aug; 36(2):427-32. PubMed ID: 12143052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of aberrant p16INK4A methylation in sera of patients with HCV-related liver diseases: An Egyptian study.
    Ahmed R; Salama H; Fouad A; Sabry D; AbdAlah el-S; Kamal M
    Med Sci Monit; 2010 Sep; 16(9):CR410-5. PubMed ID: 20802412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p16INK4A hypermethylation is associated with hepatitis virus infection, age, and gender in hepatocellular carcinoma.
    Li X; Hui AM; Sun L; Hasegawa K; Torzilli G; Minagawa M; Takayama T; Makuuchi M
    Clin Cancer Res; 2004 Nov; 10(22):7484-9. PubMed ID: 15569978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
    Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of tumor-derived methylated p16INK4a sequences in plasma, serum, and blood cells of hepatocellular carcinoma patients.
    Wong IH; Zhang J; Lai PB; Lau WY; Lo YM
    Clin Cancer Res; 2003 Mar; 9(3):1047-52. PubMed ID: 12631605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation markers and serum α-fetoprotein level are prognostic factors in hepatocellular carcinoma.
    Lin JC; Wu YC; Wu CC; Shih PY; Wang WY; Chien YC
    Ann Hepatol; 2015; 14(4):494-504. PubMed ID: 26019036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis--A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma.
    Kondo Y; Kanai Y; Sakamoto M; Mizokami M; Ueda R; Hirohashi S
    Hepatology; 2000 Nov; 32(5):970-9. PubMed ID: 11050047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative methylation analysis reveals gender and age differences in p16INK4a hypermethylation in hepatitis B virus-related hepatocellular carcinoma.
    Wang Y; Cheng J; Xu C; Liu S; Jiang S; Xu Q; Chen X; Zhuang H; Lu F
    Liver Int; 2012 Mar; 32(3):420-8. PubMed ID: 22192146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
    Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
    Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients.
    Wong IH; Lo YM; Zhang J; Liew CT; Ng MH; Wong N; Lai PB; Lau WY; Hjelm NM; Johnson PJ
    Cancer Res; 1999 Jan; 59(1):71-3. PubMed ID: 9892188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis.
    Yu J; Ni M; Xu J; Zhang H; Gao B; Gu J; Chen J; Zhang L; Wu M; Zhen S; Zhu J
    BMC Cancer; 2002 Nov; 2():29. PubMed ID: 12433278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting hepatocellular carcinoma by detection of aberrant promoter methylation in serum DNA.
    Zhang YJ; Wu HC; Shen J; Ahsan H; Tsai WY; Yang HI; Wang LY; Chen SY; Chen CJ; Santella RM
    Clin Cancer Res; 2007 Apr; 13(8):2378-84. PubMed ID: 17438096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infrequent alterations of the p16INK4A gene in liver cancer.
    Kita R; Nishida N; Fukuda Y; Azechi H; Matsuoka Y; Komeda T; Sando T; Nakao K; Ishizaki K
    Int J Cancer; 1996 Jul; 67(2):176-80. PubMed ID: 8760583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p16INK4A gene alterations are not a prognostic indicator for survival in patients with hepatocellular carcinoma undergoing curative hepatectomy.
    Anzola M; Cuevas N; Lopez-Martinez M; Martinez de Pancorbo M; Burgos JJ
    J Gastroenterol Hepatol; 2004 Apr; 19(4):397-405. PubMed ID: 15012776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent k- ras -2 mutations and p16(INK4A)methylation in hepatocellular carcinomas in workers exposed to vinyl chloride.
    Weihrauch M; Benicke M; Lehnert G; Wittekind C; Wrbitzky R; Tannapfel A
    Br J Cancer; 2001 Apr; 84(7):982-9. PubMed ID: 11286481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
    Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
    Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic alterations of INK4alpha/ARF locus and p53 in human hepatocellular carcinoma.
    Peng CY; Chen TC; Hung SP; Chen MF; Yeh CT; Tsai SL; Chu CM; Liaw YF
    Anticancer Res; 2002; 22(2B):1265-71. PubMed ID: 12168936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.